Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases

Welcome and Introduction

Date

12 Sep 2022

Session

Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases

Topics

Tumour Site

Breast Cancer

Presenters

Diana Lüftner

Authors

D.I. Lüftner

Author affiliations

  • Hemacology And Oncology, MHB - Brandenburg Medical School Theodor Fontane - Institute of Social Medicine and Epidemiology, 14770 - Brandenburg an der Havel/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

The HER2+ breast cancer pathway

Presenter: Icro Meattini

Session: Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases

Resources:

Webcast

Managing brain metastases

Presenter: Olivier Tredan

Session: Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases

Resources:

Webcast

Conclusions

Presenter: Diana Lüftner

Session: Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.